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Performance on a pattern separation task by
Alzheimer’s patients shows possible links
between disrupted dentate gyrus activity and
apolipoprotein E ∈4 status and cerebrospinal fluid
amyloid-β42 levels
Keith A Wesnes1,2,3*, Peter Annas4, Hans Basun5, Chris Edgar6 and Kaj Blennow7
Abstract
Introduction: Emerging evidence suggests that decreased adult hippocampal neurogenesis represents an early
critical event in the course of Alzheimer’s disease (AD). In mice, adult neurogenesis is reduced by knock-in alleles for
human apolipoprotein E (ApoE) ∈4. Decreased dentate gyrus (DG) neural progenitor cells proliferation has been
observed in the triple-transgenic mouse model of AD (3xTg-AD); this reduction being directly associated with the
presence of amyloid-β (Aβ) plaques and an increase in the number of Aβ-containing neurons in the hippocampus.
Cognitive tasks involving difficult pattern separations have been shown to reflect DG activity and thus potentially
neurogenesis in both animals and man. This study involved the administration of a pattern separation paradigm to
Alzheimer’s patients to investigate relationships between task performance and both ApoE status and cerebrospinal
fluid (CSF) Aβ42 levels.
Methods: The CDR System pattern separation task involves the presentation of pictures that must later be
discriminated from closely similar pictures. This paper presents pattern separation data from 66 mild to moderate
AD patients, of which 50 were genotyped and 65 in whom CSF Aβ42 was measured.
Results: ApoE ∈4 homozygotes were not compromised on the easy pattern separations compared with the other
patients, but they were statistically significantly poorer at the difficult separations. In all patients CSF Aβ42
correlated significantly with the ability to make the difficult discriminations, but not easier discriminations. Pattern
separation speed correlated negatively with CSF Aβ42, and thus the association was not due to increased
impulsivity.
Conclusions: These are, to our knowledge, the first human pattern separation data to suggest a possible genetic
link to poor hippocampal neurogenesis in AD, as well as a relationship to Aβ42. Therapies which target
neurogenesis may thus be useful in preventing the early stages of AD, notably in ApoE ∈4 homocygotes.
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Introduction
The human hippocampus supports the formation of epi-
sodic memory without confusing new memories with old
ones [1]. To accomplish this, the brain must disambiguate
memories - and this is now widely recognized as a key role
of the dentate gyrus (DG). Convergent lines of evidence
from neuroanatomical, electrophysiological, behavioral and
human brain imaging studies suggest a crucial role for the
DG in the formation of new episodic memories, by trans-
forming similar experiences or events into discrete non-
overlapping representations, a process known as “pattern
separation” [2]. Schmidt et al. [1] write: “Over the course
of the last 20 years, the overwhelming majority of data have
supported the notion of the DG as a critical mediator of
pattern separation within the hippocampal formation”
(page 57).
Human evidence from functional Magnetic Resonance
Imaging (fMRI) work has accumulated over the last few
years linking the DG and CA3 subregions to performance
on a pattern separation paradigm. Kirwan and Stark [3]
used a continuous recognition paradigm, conducted
during fMRI scanning, in which a series of pictures of
everyday objects was presented and the participants had
to classify each picture as new, similar or previously
presented. Some of the pictures were repeated across trials
and some pictures were presented that were very similar
but not identical to previously presented objects. These
latter objects, termed lures, were hypothesized to result in
increased interference and an increased need for pattern
separation due to the overlapping object features. fMRI
activity in the hippocampus was found to distinguish be-
tween correctly identified old stimuli, correctly rejected
similar lure stimuli, and false positive responses to similar
lures. A further study from this group investigated fMRI
activity in eight medial temporal lobe subregions when
participants viewed these same stimuli; that activity,
consistent with a strong bias towards pattern separation,
was observed in and limited to the DG/CA3, which the
authors interpreted as compelling evidence of a key role
of this region in pattern separation [4]. As DG activity is
known to decline with human aging, Toner et al. [5] used
the continuous recognition paradigm of Kirwan and Stark
to evaluate the effects of age on pattern separation. They
contrasted the pattern separation performance of 20
young adults with 20 adults aged over 65 years, finding
that the older adults were more likely to commit false
positive errors and identify lure stimuli as old. However,
there were no significant age-related differences in
correctly identifying first stimuli as new or repeated
stimuli as old. This was interpreted to indicate that in
non-demented adults, age-related changes in hippocampal
subregions may result in less efficient pattern separation.
Wesnes [6] evaluated data from 3,067 healthy individuals
aged from 18 to 87 years on another pattern separation
paradigm - the Clinical Dementia Rating (CDR) System
picture recognition task [7]. In this task, a series of
pictures of everyday objects and scenes is presented to the
participant, followed around 10 to 12 minutes later by a
series containing these pictures mixed with very similar
ones. The data confirmed Toner et al.’s finding that older
participants were selectively poorer at correctly rejecting
the closely similar pictures (lures), performing at the level
of younger participants when correctly identifying previ-
ously presented pictures. This finding was extended by the
demonstration that from the 20s onwards, the ability to
make the difficult discriminations (correctly identify the
lures as new) declined decade by decade from the 20s
onwards. Again no such deterioration was seen for the
ability to correctly identify the previously presented
pictures (pattern completion). One difference between the
paradigms is that the pattern separation task used by
Toner and previous groups involves continuous recogni-
tion, whereas the CDR System task has a gap of 10 to 12
minutes before the recognition phase begins. The similar-
ity of the findings in the two studies suggests that the two
paradigms are assessing a common cognitive process.
Yassa et al. [8] studied young and elderly adults in the
continuous recognition pattern separation paradigm, and
replicated Toner et al.’s finding that the elderly were
poorer at correctly rejecting previously presented pictures.
They also employed a Mnemonic Similarity Task in which
128 pictures of common objects were presented at the
rate of one every 2.5 seconds. After a delay of several
minutes, they were then shown 64 of the previous objects,
64 new objects and 64 objects that were similar but not
identical to the original objects (lures). As in the previous
study, the older participants were less likely to correctly
identify the similar objects, and further analysis indicated
that the degree of difference of the similar objects had to
be greater in order for the performance of the elderly to
match that of the young. The findings indicate that continu-
ous recognition paradigms identify more similar age-related
changes than paradigms in which recognition is delayed.
The duration of the task employed by Yassa et al. was
around 18 minutes, which is slightly longer than the CDR
System paradigm. Overall, the comparable patterns of
results between the three paradigms suggest that the CDR
System task is measuring a behavioral phenomenon similar
to continuous recognition tasks.
Yassa et al. [9], using the continuous pattern discrim-
ination task, found that patients with amnestic Mild
Cognitive Impairment (aMCI) performed at the same
level as normal age-matched controls in identifying
previously presented items, but were poorer in correctly
identifying lure items [8]. A similar finding was identified
with aMCI patients using the CDR System pattern separ-
ation task [6], again suggesting that the two paradigms
assess similar behavioral phenomena. Stark et al. [10]
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identified age-related declines in difficult pattern separa-
tions in healthy adults, replicating earlier findings [5,6].
However, when the older adults (60 years and over)
were separated based on their performance on delayed
word recall in the Rey Auditory Verbal Learning Test,
those performing more poorly also showed a deficit in
difficult pattern separations, to a level comparable to
patients with aMCI. However, in this study, the aMCI
patients were poorer than age-matched controls on both
easier and difficult pattern separations. Ally et al. [11]
studied aMCI patients and mild Alzheimer’s disease (AD)
patients in the pattern separation task used previously (for
example, [3]). They identified that pattern separation was
impaired in aMCI and further impaired in mild AD,
whereas pattern completion was unaffected in aMCI but
impaired in mild AD.
The seminal discovery, that in humans the DG retains
its ability to generate neurons throughout life [12], has
raised the possibility that therapies could be developed
to protect or promote such neurogenesis, as it deterio-
rates due to ageing, insult and disease. Ageing itself
results in a marked decline in adult brain neural stem/
progenitor cells and neurogenesis, with concomitant
impairments to cognitive functions [13]. Another major
milestone occurred on 28 August 2013 when a team of
Columbia University Medical Center researchers, led by
Nobel laureate Eric Kandel, published a paper in the
online edition of Science Translational Medicine, which
identified the deficiency of a protein (RbAp48) in the
hippocampal DG to be a significant contributor to age-
related memory loss, and also demonstrated that this
memory loss is reversible [14]. This finding builds on
previous proposals that memory disturbances both in
normal ageing and the early stages of Alzheimer’s dis-
ease could result from degenerative changes which com-
promise neurogenesis in the DG [15].
Lazarov and Marr [16] write: “While a massive and
progressive neuronal loss in specific areas such as the
hippocampus and cortex unequivocally underlies cogni-
tive deterioration and memory loss in Alzheimer's
disease, noteworthy alterations take place in the neuro-
genic microenvironments, namely, the subgranule layer
of the dentate gyrus and the subventricular zone. Com-
promised neurogenesis presumably takes place earlier
than onset of hallmark lesions or neuronal loss, and may
play a role in the initiation and progression of neuropath-
ology in Alzheimer's disease” (page 267). In mice, adult
neurogenesis can be reduced by knock-out alleles for
apolipoprotein E (ApoE), as well as by knock-in alleles for
human ApoE ∈4 [17]. Decreased DG neural progenitor
cell proliferation has been observed in 3xTg-AD mice; this
reduction being directly associated with the presence of Aβ
plaques and an increase in the number of Aβ-containing
neurons in the hippocampus [18].
Overall, behavioral evidence is accumulating from
pattern separation paradigms that DG activity and, thus,
possibly neurogenesis, declines in human normal ageing
and does so at a greater rate in aMCI and mild AD. The
purpose of the present analysis was: (1) to use data from
the CDR System pattern separation task to compare the
performance of AD patients on the task to that of age-
matched controls; (2) to determine whether in AD, a
profile could be detected which was consistent with pre-
clinical findings of a linkage of ApoE ∈4 to compromised
DG neurogenesis [17]; and (3) to determine whether AD
patients’ performances on the task could provide evi-
dence consistent with the established relationship of Aβ
to decreased DG neural progenitor cells [18].
Methods
Participants
Sixty six (31 female) mild to moderate Alzheimer’s disease
patients (Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV)), aged from 59 to
100 years (mean 76.6, SD 7.5), with mean mini–mental
state examination (MMSE) scores of 23.9 (SD 3.6; range
16 to 30) and Alzheimer’s Disease Assessment Scale –
cognitive subscale (ADAS-cog) scores of 14.2 (SD 6.8;
range 1.33 to 31.7) participated in this study. Participants
were on stable, continuous treatment with acetylcholin-
esterase inhibitors, but were not included if treated with
memantine, lithium, warfarin or recently started (less than
three months) central nervous system active substances
(for example, anti-depressants and neuroleptics). Partici-
pants with other concomitant diseases which might inter-
fere with the study objectives were also excluded. All
participants provided signed, written informed consent as
well as that of a relative⁄legal representative, and were
deemed able to comply with the study procedures. The
study was conducted according to the provisions of the
Helsinki Declaration and was approved by the Ethics
Committees of the Universities of Lund and Uppsala and
at the Karolinska Institute, Stockholm, Sweden.
Control data were taken from the CDR System database
and comprised 238 individuals (104 female) aged from 71
to 91 (mean age 76.9, SD 4.1), with mean MMSE scores of
28.9 (SD 1.1).
Procedure
The study was a three-center (Malmo University Hospital,
Huddinge University Hospital and Uppsala University
Hospital), open-study conducted over 18 months between
2004 and 2005. Participants completed a maximum of
three hospital visits. At an initial visit, written informed
consent was obtained, and at a subsequent visit within
four weeks, participants completed various tests, including
the CDR System pattern separation and underwent cere-
brospinal fluid (CSF) and blood sampling.
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CSF and blood sampling
CSF (8 ml) was collected according to hospital routine
and transferred to polypropylene test tubes. Cellular ma-
terial was pelleted by centrifuge within 30 minutes
(1,500 × g, + 4°C for 15 minutes), then frozen in 2 ml
aliquots and stored at -70°C [19]. Genotyping was con-
ducted from the blood samples.
Cognitive testing
The CDR System [6,7,20,21] Picture Recognition Task
was used. In this task a series of 14 pictures of everyday
scenes and objects was presented on the screen at the
rate of one every four seconds for the participant to
remember. Around 12 minutes later the 14 pictures
were re-presented mixed with 14 novel pictures which
were individually matched to the original pictures to be
closely similar. For each picture the participant was
required to decide whether it was either an originally
presented picture or a novel picture, by pressing a YES
or NO button as appropriate, and as quickly as possible.
The percentage of correctly identified previously pre-
sented pictures (pattern completion) was recorded as
well as the percentage of correctly rejected novel but
closely similar pictures (pattern separation). For each
type of discrimination, speed of response in milliseconds
was also recorded.
The participants also performed three CDR System
tests of attention: simple reaction time, choice reaction
time and digit vigilance [20,21]. The speed scores from
these three tasks are combined to provide an index of
focussed attention and an information process named
Power of Attention, which has been validated by factor
analysis [21].
Statistics
All analyses were performed using the SAS® System (SAS
Institute, Cary, North Carolina, USA). Differences between
AD participants and controls were analyzed using mixed
model analyses of covariance (ANCOVA). For each
ANCOVA, a fixed term was fitted to the model for type
(control or participant) and a random term for partici-
pants. Age was fitted as a covariate. Differences on various
measures between the ApoE genotypes were evaluated by
mixed model ANCOVAs. For each ANCOVA, a fixed term
was fitted to the model for the ApoE genotype and a ran-
dom term for participants. Age was fitted as a covariate.
Other exploratory covariates were fitted and reported. As-
sociations between measures were evaluated by calculating
Spearman's Rho correlation coefficients.
Results
Although some findings from this study have been re-
ported previously [20], none of the data presented here has
previously been published. CDR System pattern separation
data were available for all participants, CSF Aβ42 levels for
65 participants and ApoE genotyping for 50.
Comparisons to controls
There were highly significant differences on the task
for the ability to correctly identify the original pictures
(F(1,301) = 124.4, P <0.0001) and the ability to identify the
closely similar pictures (F(1,301) = 68.4, P <0.0001). For
the original pictures, the deficit in the AD patients com-
pared to controls was 16.1% (95% confidence intervals
13.3 to 19), while for the closely similar pictures the deficit
was 15.8% (95% confidence intervals 12 to 19.5).
ApoE genotype
There were five ApoE genotypes (see Table 1). Inspection
of the accuracy scores indicates that the ApoE ∈4/∈4
genotype scored notably lower than the other genotypes
on the difficult pattern separations but not on the easier
separations. The difference on the difficult pattern separa-
tions between the ∈4/∈4 genotype and the other four
genotypes was 33.4% on average. However, the ∈4/∈4
genotype was younger than the other four genotypes by
five to seven years, and age therefore was fitted to the
ANCOVA models as a covariate. The analysis found a
significant main effect of genotype for the difficult pattern
discriminations (F(4.44) = 3.5, P = 0.0168) but not the
simple ones (F(4.44) = 0.1, P = 0.99). The least squares
means from the ANCOVAs of the easy and difficult
separations are plotted in Figure 1 with 95% confidence
intervals (CI). Focusing on the difficult pattern separa-
tions, it can be seen that the CI for the ∈4/∈4 genotype do
not overlap the least squares means of the other four ge-
notypes, nor do the CIs of the other four genotypes over-
lap the least squares mean of the ∈4 homozygotes. The
Cohen’s d effect sizes of the differences between the ∈4/∈4
genotype and the other groups ranged from 1.3 and 1.8,
and thus exceeded the convention of large effects for this
measure (0.8), making the differences of clear clinical
relevance.
To determine whether this effect could simply be due
to overall differences in cognitive ability between the five
cohorts, the two standard scales were also subject to
ANCOVA, but no significant main effects of genotype
were identified for either MMSE (P >0.3) or ADAS-cog
(P >0.49). To examine the possibility that the observed
differences in difficult pattern separations may be related
to poorer visual information processing in the homozy-
gotes - the measure of focused attention and informa-
tion processing (Power of Attention) was also fitted as a
covariate, but the main effect of genotype still remained
(P = 0.0181). Finally, there were clear differences be-
tween the genotypes in the levels of Aβ42, which were
highly significant (P = 0.0034), although when Aβ42 was
fitted as a covariate, the main effect remained (P = 0.0157).
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Table 1 Demographics, cognitive test scores and CSF biomarker levels for the five genotypes (means with SD)
ApoE
Genotype
n AgeYears MMSE ADAS-Cog Picture recognition-pattern separation task Power of
attention
Aβ42 P-tau T-tau
Difficult separations Easy separations msec
% Correct Speed % Correct Speed
∈2/∈3 5 77 (10) 22 (5) 15 (8) 70 (28) 2,981 (3,137) 81 (15) 1,384 (443) 1,555 (296) 715 (113) 63 (17) 457 (147)
∈3/∈3 10 75 (9) 23 (4) 15 (10) 77 (26) 2,393 (1,450) 81 (17) 1,774 (1639) 1,621 (596) 536 (316) 76 (27) 555 (214)
∈4/∈2 2 75 (10) 26 (1) 9 (1) 79 (0) 1,078 (280) 86 (10) 1,099 (262) 1,430 (326) 439 (256) 66 (35) 535 (274)
∈4/∈3 28 76 (6) 25 (4) 13 (7) 82 (21) 1,830 (1,197) 82 (24) 1,483 (972) 1,504 (459) 414 (179) 99 (45) 748 (395)
∈4/∈4 5 70 (6) 22 (3) 19 (3) 44 (24) 4,263 (5,567) 84 (11) 2,132 (1,621) 1,579 (457) 295 (60) 97 (12) 769 (146)
ADAS-cog, Alzheimer’s Disease Assessment Scale – cognitive subscale; ApoE, apolipoprotein E; CSF, cerebrospinal fluid; MMSE, mini–mental state examination.
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A final consideration was that the response style may
have been different in the ∈4/∈4 genotype; these partici-
pants, for example, may have been more impulsive, and
made less correct rejections of the different but similar
pictures by responding more quickly. ANCOVAs run on
the speed scores found no overall effects for either the
easy discriminations (F(4,43) = 0.8, P = 0.5326) or the dif-
ficult ones (F(4,44) = 1.81, P = 0.1433). However, paired-t
comparisons did identify a slower speed of the ∈4/∈4
group in making the difficult discriminations compared to
the ∈4/∈3 group (P = 0.0168), with trends for the ∈3/∈3
(P = 0.0877) and ∈4/∈2 groups (P = 0.0706). As can be
seen in Table 1, the response times in the ∈4/∈4 group
were between 43% and 295% longer than the other
genotypes. This indicates that not only did the ∈4/∈4
group find the difficult discriminations harder, and thus
made less correct rejections, but that they also took
longer to do so as a consequence, though the increased
reaction times are only of marginal statistical reliability.
What is clear is that for the ∈4/∈4 group, accuracy on
the difficult discriminations was not being compro-
mised at the expense of speed of responding.
Relationship of CSF Aβ42 levels to the performance on
the Pattern Separation task
Although Aβ42 levels were not responsible for the
differences between the five genotypes on difficult
pattern separations, transgenic mice 3xTg-AD (who have
greater Aβ pathology) show reduced DG neural progeni-
tor cell proliferation, this reduction being directly associ-
ated both with the presence of Aβ plaques, and also an
increase in the number of Aβ-containing neurons in the
hippocampus [18]. To determine whether, for the 65
participants whose Aβ42 levels had been measured,
there was a relationship between Aβ42 and the perform-
ance on the pattern separation task, correlations were
performed. These are summarized in Table 2, from
which it can be seen that higher levels of Aβ42 were
significantly associated with greater accuracy in the 65
participants on the difficult separations, and also with
faster response to these stimuli. In contrast, there was
no significant association with the accuracy of the easy
discriminations. Although the coefficients are modest,
Pattern Separation Task - Accuracy of Detection
LS Means and 95% Confidence Intervals
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Figure 1 Comparison of the scores of the ApoE genotypes on the Pattern Separation Task. ApoE, apolipoprotein E; CDR, Clinical Dementia
Rating; DG, dentate gyrus.
Table 2 Pearson Correlations of CSF biomarkers with
performance measures from the Pattern Separation Task
Task measures Aβ42 T-tau P-tau
Rho P Rho P Rho P
Easy separations % correct 0.13 0.312 0.03 0.81 0.09 0.47
Difficult separations % correct 0.32 0.0106 -0.09 0.46 -0.05 0.71
Easy separations speed -0.3 0.0166 0.19 0.14 0.09 0.46
Difficult separations speed -0.38 0.0021 0.05 0.67 -0.05 0.7
CSF, cerebrospinal fluid.
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they do exceed the convention for Pearson coefficients
of medium effect sizes (0.3) and are also of clinical
relevance.
Although no expectation was made of relationships
between Tau, the correlations are presented for illustra-
tive purposes in Table 2, but as can be seen, there was
little association.
Discussion
In the present study, Alzheimer’s patients showed signifi-
cant deficits on the aspects of the CDR System Picture
Recognition task which reflected pattern completion (cor-
rectly identifying original pictures), as well as the part
which reflected pattern separation (correctly identifying
the closely similar pictures). The deficits on the two as-
pects of performance were very close in magnitude. This
finding is consistent with that of Ally et al. [11]. However,
the AD patients who were ApoE ∈4 homozygotes were
statistically significantly poorer at the pattern separation
part of the task, but not on the ability to recognize the
previously presented pictures, which reflects pattern com-
pletion. These participants also showed numerically
slower speed in rejecting the closely similar pictures. This
was thus an unequivocal impairment: poorer accuracy
being accompanied by slower speed. The effect sizes of
these impairments were notable and of clear clinical and
everyday relevance. When correlations were performed
between these task measures and CSF Aβ42, a significant
association was detected between the ability to correctly
reject the closely similar pictures and levels of Aβ42,
which exceeded a medium effect size, and thus also could
be considered clinically relevant. In animals, performance
on pattern separation tasks is related to DG activity and
neurogenesis, with reduced ability to make difficult dis-
criminations (pattern separation) being associated with
disruption to the DG and impaired neurogenesis [2,22].
Further, animals with strongly reduced levels of dentate
gyrus neurogenesis have been shown to be impaired in a
hippocampus-dependent object recognition task [23].
These data therefore suggest that the ApoE ∈4 homozy-
gotes have greater impairments to the DG than the other
ApoE groupings. Although this relationship did not
disappear when Aβ42 levels were used as covariates, sep-
arate analyses identified Aβ42 levels to be related to the
ability to make difficult separations. This suggests two
possibly independent risk factors of reduced DG activity
in AD: having two ApoE ∈4 alleles or having lowered CSF
levels of Aβ42.
Overall, to our knowledge, these are the first pattern
separation data from Alzheimer’s patients which provide
evidence that pattern separation deficits are related both
to ApoE ∈4 genotypes and CSF Aβ42. The data are
consistent with previous findings of compromised per-
formance on this measure in normal aging and, also, the
greater impairment seen in the Alzheimer’s disease
prodrome - amnestic MCI. While until recently the
relationship to pattern separation tasks, DG activity and
neurogenesis has not been confirmed in humans, the
data just published by Mandel and colleagues identified
the RbAp48 protein to be specifically lower in human
post mortem dentate gyrus tissue [14]. The group then
went on to manipulate the protein in mice and found
clear relationships to age-related memory decline (also
associated with fMRI evidence of selectively observed
DG dysfunction), which corresponded to a regionally
selective decrease in histone acetylation (itself directly
associated with reduced neurogenesis). While Mandel
and colleagues interpret their results in terms of normal
aging as opposed to AD pathology, our findings tenta-
tively suggest that this mechanism may also be involved
in pathological ageing associated with a known CSF bio-
marker for AD, as well as a known genetic predispos-
ition for the disease.
Drug development for AD is currently moving to earl-
ier manifestations of the disease, that is, the prodromal
MCI stage, or even to the preclinical stage. This latter
direction has been stimulated by recently published
operational research criteria for preclinical AD [24], and
therapeutic trials are already underway [25]. Preclinical
AD patients are cognitively normal, and thus patients
need to be initially identified upon the basis of genetic
predisposition or the presence of relevant biomarkers.
Further, recent regulatory guidance from the FDA has
indicated that in preclinical AD, approval may be given
on the basis of cognitive task data alone [26]. The
analyses reported in this paper suggest that trials of ther-
apies which target hippocampal neurogenesis in preclin-
ical or prodromal AD may benefit from the targeted
selection of participants with reduced CSF Aβ42 and/or
those with two ApoE ∈4 alleles. Finally, enhanced DG
neurogenesis has been recently shown in animal models
to result in improved performance in pattern separation
tasks [2]. Thus, in therapeutic preclinical AD trials of
compounds, which as (or as part of ) their mechanism of
action target neurogenesis, pattern separation tasks
could provide a proof of mechanism of action, while at
the same time serving as part of the assessment of thera-
peutic effectiveness.
Conclusions
Mild to moderate AD patients showed a pattern of results
on a pattern separation test consistent with disrupted
activity in the hippocampal dentate gyrus. fMRI studies
have identified that the ability to make difficult object pat-
tern separations in such tests is associated with selectively
increased activity in the DG/CA3 region. In this study, the
difficult pattern separation measure was selectively
impaired in ApoE ∈4 homozygotes, and was also related
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to CSF levels of Aβ42. These findings are consistent with
preclinical findings of a linkage of ApoE ∈4 to compro-
mised DG neurogenesis, and also the established relation-
ship of Aβ to decreased DG neural progenitor cells. These
are to our knowledge the first human pattern separation
data to suggest a possible genetic link to poor hippocam-
pal neurogenesis in AD, as well as a relationship to Aβ42.
Thus, therapies which target hippocampal neurogenesis
may be useful in treating the early stages of AD, notably in
ApoE ∈4 homocygotes or those showing reduced levels of
Aβ42. Further, in such trials, pattern separation tasks
could serve both as a proof of mechanism and an efficacy
measure.
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